1. Home
  2. PATH vs RGEN Comparison

PATH vs RGEN Comparison

Compare PATH & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PATH
  • RGEN
  • Stock Information
  • Founded
  • PATH 2005
  • RGEN 1981
  • Country
  • PATH United States
  • RGEN United States
  • Employees
  • PATH N/A
  • RGEN N/A
  • Industry
  • PATH Computer Software: Prepackaged Software
  • RGEN Medical/Dental Instruments
  • Sector
  • PATH Technology
  • RGEN Health Care
  • Exchange
  • PATH Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • PATH 7.1B
  • RGEN 8.0B
  • IPO Year
  • PATH 2021
  • RGEN N/A
  • Fundamental
  • Price
  • PATH $12.19
  • RGEN $118.85
  • Analyst Decision
  • PATH Hold
  • RGEN Buy
  • Analyst Count
  • PATH 18
  • RGEN 11
  • Target Price
  • PATH $13.97
  • RGEN $172.67
  • AVG Volume (30 Days)
  • PATH 13.6M
  • RGEN 736.8K
  • Earning Date
  • PATH 05-29-2025
  • RGEN 07-29-2025
  • Dividend Yield
  • PATH N/A
  • RGEN N/A
  • EPS Growth
  • PATH N/A
  • RGEN N/A
  • EPS
  • PATH N/A
  • RGEN N/A
  • Revenue
  • PATH $1,451,176,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • PATH $10.73
  • RGEN $13.93
  • Revenue Next Year
  • PATH $8.72
  • RGEN $14.35
  • P/E Ratio
  • PATH N/A
  • RGEN N/A
  • Revenue Growth
  • PATH 7.21
  • RGEN 4.88
  • 52 Week Low
  • PATH $9.38
  • RGEN $102.97
  • 52 Week High
  • PATH $15.93
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • PATH 43.26
  • RGEN 39.78
  • Support Level
  • PATH $12.17
  • RGEN $120.68
  • Resistance Level
  • PATH $12.59
  • RGEN $135.30
  • Average True Range (ATR)
  • PATH 0.39
  • RGEN 4.93
  • MACD
  • PATH -0.14
  • RGEN -0.64
  • Stochastic Oscillator
  • PATH 9.95
  • RGEN 18.40

About PATH UiPath Inc.

UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: